Shenzhen Bioeasy Biotechnology Past Earnings Performance
Past criteria checks 0/6
Shenzhen Bioeasy Biotechnology's earnings have been declining at an average annual rate of -46.9%, while the Medical Equipment industry saw earnings growing at 7% annually. Revenues have been declining at an average rate of 17.9% per year.
Key information
-46.9%
Earnings growth rate
-47.7%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | -17.9% |
| Return on equity | -19.5% |
| Net Margin | -71.3% |
| Next Earnings Update | 30 Aug 2024 |
Revenue & Expenses Breakdown
How Shenzhen Bioeasy Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 230 | -164 | 148 | 45 |
| 31 Dec 23 | 254 | -185 | 155 | 53 |
| 30 Sep 23 | 280 | -165 | 131 | 99 |
| 30 Jun 23 | 324 | -138 | 144 | 111 |
| 31 Mar 23 | 454 | -59 | 136 | 114 |
| 01 Jan 23 | 687 | 83 | 155 | 111 |
| 30 Sep 22 | 739 | 189 | 176 | 87 |
| 30 Jun 22 | 742 | 225 | 146 | 84 |
| 31 Mar 22 | 745 | 263 | 128 | 77 |
| 01 Jan 22 | 598 | 237 | 102 | 72 |
| 30 Sep 21 | 503 | 209 | 86 | 54 |
| 30 Jun 21 | 457 | 190 | 85 | 50 |
| 31 Mar 21 | 333 | 118 | 85 | 41 |
| 31 Dec 20 | 258 | 65 | 75 | 39 |
| 30 Sep 20 | 282 | 90 | 118 | 62 |
| 31 Mar 20 | 269 | 114 | 60 | 35 |
| 31 Dec 19 | 239 | 92 | 61 | 32 |
| 31 Dec 18 | 205 | 74 | 47 | 23 |
| 31 Dec 17 | 138 | 39 | 45 | 22 |
| 31 Dec 16 | 87 | 23 | 31 | 16 |
Quality Earnings: 300942 is currently unprofitable.
Growing Profit Margin: 300942 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300942 is unprofitable, and losses have increased over the past 5 years at a rate of 46.9% per year.
Accelerating Growth: Unable to compare 300942's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 300942 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (0.7%).
Return on Equity
High ROE: 300942 has a negative Return on Equity (-19.46%), as it is currently unprofitable.